Protalix BioTherapeutics ... (PLX)

AMEX: PLX · Real-Time Price · USD

3.00

0.00 (0.00%)

At close: May 02, 2025, 3:59 PM

3.05

1.49%

After-hours: May 02, 2025, 04:55 PM EDT

Protalix BioTherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	19.76M	23.63M	17.11M	38.98M	18.27M	17.79M	37.81M	51.16M	63.28M
Short-Term Investments	15.07M	20.93M	5.07M	38.98M	20.28M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	462K	528K	1.27M	2.08M	1.8M	1.96M	1.76M	1.89M	1.68M
Receivables	2.91M	5.27M	4.59M	3.44M	2M	4.7M	4.73M	1.72M	693K
Inventory	21.24M	19.05M	16.8M	17.95M	13.08M	8.15M	8.57M	7.83M	5.25M
Other Current Assets	596K	611K	536K	380K	1.25M	1.52M	1.42M	1.5M	2.23M
Total Current Assets	60.08M	69.93M	44.88M	61.67M	55.72M	32.48M	52.98M	62.65M	71.87M
Property-Plant & Equipment	10.02M	10.88M	9.64M	9.92M	10.41M	10.95M	6.39M	7.68M	8.7M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	13.34M	14.5M	10.91M	12M	12.21M	12.91M	8.15M	9.56M	10.38M
Total Assets	73.42M	84.43M	55.79M	73.67M	67.93M	45.39M	61.13M	72.21M	82.25M
Account Payables	4.53M	4.32M	5.86M	6.99M	7.22M	6.5M	5.21M	7.52M	4.01M
Deferred Revenue	n/a	n/a	13.18M	8.55M	5.39M	16.34M	9.87M	26.85M	837K
Short-Term Debt	1.5M	21.66M	1.12M	1.21M	58.51M	4.3M	n/a	5.92M	53.87M
Other Current Liabilities	1.81M	4.94M	9.94M	13.14M	12.47M	10.52M	9.18M	526K	1.4M
Total Current Liabilities	25.62M	45.53M	32.43M	33.18M	86.47M	40.17M	25.35M	22.75M	66.21M
Long-Term Debt	n/a	n/a	28.19M	27.89M	n/a	50.96M	47.97M	46.27M	23.64M
Other Long-Term Liabilities	4.58M	714K	1.64M	2.47M	2.31M	3.07M	7.67M	7.64M	2.35M
Total Long-Term Liabilities	4.58M	5.33M	34M	46.52M	8.5M	75.54M	88.66M	80.75M	25.99M
Total Liabilities	30.21M	50.87M	66.43M	79.7M	94.97M	115.71M	114.01M	103.51M	92.2M
Total Debt	5.53M	26.28M	33.47M	33.47M	64.4M	60.92M	47.97M	52.19M	77.52M
Common Stock	76K	73K	54K	46K	35K	15K	148K	144K	124K
Retained Earnings	-378.39M	-381.55M	-389.86M	-374.93M	-347.35M	-340.83M	-322.55M	-297.93M	-212.66M
Comprehensive Income	n/a	n/a	n/a	0.00	n/a	n/a	-29.12M	-27.46M	-25.6M
Shareholders Equity	43.21M	33.57M	-10.64M	-6.04M	-27.04M	-70.32M	-52.88M	-31.29M	-9.96M
Total Investments	15.07M	20.93M	5.07M	38.98M	20.28M	n/a	n/a	n/a	n/a